Replay available

Bonesupport Holding AB (publ) (BONEX) Q1 2026 Earnings Call

Bonesupport Holding AB (publ) (STO: BONEX) Q1 2026 earnings conference call, held 2026-04-22. Replay captured from the company's public earnings webcast.

Wed, April 22, 2026 at 4:00 AMendedReplay
Bonesupport Holding AB (publ) (BONEX) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Håkan Johansson

CFO

Torbjörn Sjöld

CEO

Oscar Bergman

Analyst, Red Eye

Sten Gustafson

Analyst, ABG Sundal Collier

Christopher Lilliburg

Analyst, DNB Carnegie

Matthias Vadsen

Analyst, SEB

Replay transcript excerpt

Welcome to Bone Support Q1 2026. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to CEO Torbjörn Schold and CFO Håkon Johansson. Please go ahead. Thank you, Operator. Welcome, everyone, to Bone Support's Q1 2026 results call. My name is Torbjörn Sjöld, CEO of Bone Support. With me here today is our CFO, Håkan Johansson, and together we will use the next 25 minutes to guide you through the Q1 presentation and then open the line for questions. Before starting the presentation, I would like to draw your attention to the disclaimers covering any forward-looking statements we will make today. So let's look at the financial and operational highlights of the quarter. Q1 was another strong quarter with solid execution across the business. Net sales came in at 224 million SEC, corresponding to a growth at constant exchange rates of 31% versus Q1 2025. Reported growth was 14%, showing that there was a continued strong currency impact on our figures for the quarter. Our adjusted operating result excluding incentive program effects was 85 million SEC corresponding to an adjusted operating margin of 26%. Reported operating result was 72 million SEC. We saw another quarter of solid cash generation with operating cash flows reaching 75 million SEC resulting in a cash position of 455 million SEC at quarter end. We continue to see strong traction for CermetG in the U.S., with sales reaching 222 million SEC for the quarter, compared with 178 million SEC in Q1 2025. The sequential CermetG growth, quarter over quarter of 2.6 million U.S. dollars, was the strongest ever. In Europe an...

More from Bonesupport Holding Ab